1-11 of 11
Carl Hay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models

Alexandra Borodovsky, Yanjun Wang, Minwei Ye, Joseph C. Shaw, Kris Sachsenmeier, Nanhua Deng, Kelly Goodwin, James D. Clarke, Richard Goodwin, Nicole Strittmatter, Carl Hay, Vasu Sah, Lawson Deborah, Corinne Reimer, Miles Congreve, Jonathan Mason, Fiona Marshall, Paul Lyne, Richard Woessner
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3751.
https://doi.org/10.1158/1538-7445.AM2018-3751
Published: 01 July 2018
View articletitled, Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models
Journal Articles

Abstract LB-117: Role of ectoenzymes CD39 and CD73 in the immune response to multiple myeloma

Rui Yang, Samah Elsaadi, Kristine Misund, Geir Slupphaug, Eline Menu, Carl Hay, Zac Cooper, Karin Vanderkerken, Magne Børset, Anne Marit Sponaas
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-117.
https://doi.org/10.1158/1538-7445.AM2018-LB-117
Published: 01 July 2018
View articletitled, Abstract LB-117: Role of ectoenzymes CD39 and CD73 in the immune response to multiple myeloma
Journal Articles

Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression

Alexandra Borodovsky, Yanjun Wang, Minwei Ye, Joseph C. Shaw, Kris F. Sachsenmeier, Nanhua Deng, Kelly J. DelSignore, Adrian J. Fretland, James D. Clarke, Richard J. Goodwin, Nicole Strittmatter, Carl Hay, Vasu R. Sah, Deborah Lawson, Corinne Reimer, Miles Congreve, Jonathan S. Mason, Fiona H. Marshall, Paul Lyne, Richard Woessner
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5580.
https://doi.org/10.1158/1538-7445.AM2017-5580
Published: 01 July 2017
View articletitled, Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression
Journal Articles

Abstract 285: MEDI9447: enhancing anti-tumor immunity by targeting CD73 In the tumor microenvironment

Carl Hay, Erin Sult, Qihui Huang, Scott Hammond, Kathy Mulgrew, Kelly McGlinchey, Stacy Fuhrmann, Raymond Rothstein, Edmund Poon, Ross Stewart, Robert Hollingsworth, Kris Sachsenmeier
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 285.
https://doi.org/10.1158/1538-7445.AM2015-285
Published: 01 August 2015
View articletitled, Abstract 285: MEDI9447: enhancing anti-tumor immunity by targeting CD73 In the tumor microenvironment
Journal Articles

Abstract 272: Checkpoint inhibitor combinations in a human mixed leukocyte reaction

Erin Sult, Carl Hay, Qihui Huang, Stacy Fuhrmann, Robert Hollingsworth, Kris F. Sachsenmeier
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 272.
https://doi.org/10.1158/1538-7445.AM2015-272
Published: 01 August 2015
View articletitled, Abstract 272: Checkpoint inhibitor combinations in a human mixed leukocyte reaction
Journal Articles

Abstract 4635: The avidity hypothesis: comparing bispecific and monospecific antibodies in preclinical oncology models.

Kris F. Sachsenmeier, Nazzareno Dimasi, Qihui Huang, Erin Sult, Binyam Bezabeh, Ryan Fleming, Carl Hay, Helen Zhong, Shannon Breen, Changshou Gao, Balaji Agoram, Lutz Jermutus, Robert Hollingsworth
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4635.
https://doi.org/10.1158/1538-7445.AM2013-4635
Published: 15 April 2013
View articletitled, Abstract 4635: The avidity hypothesis: comparing bispecific and monospecific antibodies in preclinical oncology models.
Journal Articles

Abstract 4328: Phenotypic selection for identification of functional antibodies and development of high throughput screening assays.

Carl Hay, Steven Rust, Erin Sult, Lori Clarke, Kim Rosenthal, Sandrine Guillard, David Lowne, Matt Flynn, Lutz Jermutus, Ralph Minter, Robert Hollingsworth, Kris Sachsenmeier
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4328.
https://doi.org/10.1158/1538-7445.AM2013-4328
Published: 15 April 2013
View articletitled, Abstract 4328: Phenotypic selection for identification of functional antibodies and development of high throughput screening assays.
Journal Articles

Abstract 974: New target discovery for oncology utilizing phenotypic selection and primary NSCLC patient tumors

Nicholas M. Holoweckyj, Alan Sandercock, Sandrine Guillard, Steven Rust, Carl Hay, Erin Brand, John Meekin, Qihui Huang, Kris Sachsenmeier, Robert E. Hollingsworth, Ralph Minter, Emma Bowden
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 974.
https://doi.org/10.1158/1538-7445.AM2012-974
Published: 15 April 2012
View articletitled, Abstract 974: New target discovery for oncology utilizing phenotypic selection and primary NSCLC patient tumors
Journal Articles

Abstract #2876: Isolation of novel functional anticancer antibodies by phage display

Kris Sachsenmeier, Sandrine Guillard, Steven Rust, David Lowne, Arthur Lewis, Carl Hay, Erin Brand, David Tice, Lutz Jermutus, Ralph Minter
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2876.
Published: 01 May 2009
View articletitled, Abstract #2876: Isolation of novel functional anticancer antibodies by phage display
Journal Articles

Systemic Gene-Directed Enzyme Prodrug Therapy of Hepatocellular Carcinoma Using a Targeted Adenovirus Armed with Carboxypeptidase G2

Silke Schepelmann, Paul Hallenbeck, Lesley M. Ogilvie, Douglas Hedley, Frank Friedlos, Janet Martin, Ian Scanlon, Carl Hay, Lynda K. Hawkins, Richard Marais, Caroline J. Springer
Journal: Cancer Research
Cancer Res (2005) 65 (12): 5003–5008.
https://doi.org/10.1158/0008-5472.CAN-05-0393
Published: 15 June 2005
View articletitled, Systemic Gene-Directed Enzyme Prodrug Therapy of Hepatocellular Carcinoma Using a Targeted Adenovirus Armed with Carboxypeptidase G2
Open the PDF for Systemic Gene-Directed Enzyme Prodrug Therapy of Hepatocellular Carcinoma Using a Targeted Adenovirus Armed with Carboxypeptidase G2 in another window
Journal Articles

An Oncolytic Adenovirus Selective for Retinoblastoma Tumor Suppressor Protein Pathway-defective Tumors: Dependence on E1A, the E2F-1 Promoter, and Viral Replication for Selectivity and Efficacy

John L. Jakubczak, Patricia Ryan, Mario Gorziglia, Lori Clarke, Lynda K. Hawkins, Carl Hay, Ying Huang, Michele Kaloss, Anthony Marinov, Sandrina Phipps, Anne Pinkstaff, Pamela Shirley, Yelena Skripchenko, David Stewart, Suzanne Forry-Schaudies, Paul L. Hallenbeck
Journal: Cancer Research
Cancer Res (2003) 63 (7): 1490–1499.
Published: 01 April 2003
View articletitled, An Oncolytic Adenovirus Selective for Retinoblastoma Tumor Suppressor Protein Pathway-defective Tumors: Dependence on E1A, the E2F-1 Promoter, and Viral Replication for Selectivity and Efficacy
Open the PDF for An Oncolytic Adenovirus Selective for Retinoblastoma Tumor Suppressor Protein Pathway-defective Tumors: Dependence on E1A, the E2F-1 Promoter, and Viral Replication for Selectivity and Efficacy in another window